Financials
- Market Capitalization 381.99 M
- Employee 45
- Founded 2019
- CEO N/A
- Website www.x4pharma.com
- Headquarter Delaware, United States
- FIGI BBG001J1CYH8
- Industry Biyoteknoloji
Toplam gelir
Net kar
Temel hisse başına kazanç (Temel EPS)
Toplam borç
Serbest nakit akışı
Nakit ve eşdeğerleri
Fiyat/kazanç oranı
-2.14
Fiyat/satışlar oranı
26.03
Related tickers
| # | Ad | Fiyat | 24s % | 7g % | 1A % | 1Y % | Piyasa Değeri | Son 7 Gün | |
|---|---|---|---|---|---|---|---|---|---|
| 3109 | AUTL Autolus Therapeutics plc - American Depositary Shares | 1.48 USD | -8.07% | -9.20% | -8.64% | -44.36% | 393.91 M USD | ||
| 3121 | LRMR Larimar Therapeutics, Inc. - Common Stock | 3.73 USD | -12.85% | +11.34% | +6.27% | +6.27% | 387.48 M USD | ||
| 3133 | AVIR Atea Pharmaceuticals, Inc. - common stock | 4.74 USD | -5.01% | -3.27% | +6.28% | +47.66% | 379.33 M USD | ||
| 3147 | FENC Fennec Pharmaceuticals Inc. - Common Stock | 10.75 USD | +2.48% | -0.46% | +18.78% | +21.47% | 373.42 M USD |